Affiliation:
1. Istanbul Medipol University, School of Engineering and Natural Sciences Istambul
Abstract
Multiple sclerosis (MS) is an autoimmune disease that affects more than 1 million people worldwide. Since there is no definitive treatment for the disease, the treatment plan for each patient should be updated regularly according to the current level of the disease. There are standard clinical tests, each with its own scoring scale, used to monitor the deterioration of upper and lower extremity functions of MS patients under the supervision of a neurologist and physiotherapist. However, non-objective scoring based on the opinion of the physiotherapist is open to erroneous assessments and may vary from person to person. In addition, clinical tests do not provide detailed information about the functional impairment of the patient. Unfortunately, an objective evaluation system has not yet been implemented all over the world, and the treatment plan is still determined according to the disease in neurological-based disabilities, such as MS, which is of vital importance. personal assessment. To address the aforementioned problem, the design and experimental evaluation of a wearable thimble-like device that can be substituted for the standard clinical tests to assess the follow-up of MS are presented. The device provides the measurement of high sensitivity and opportunity for objective assessment and allows patients of all ages to use it in any desired place during their treatment phase.
Publisher
Balkan Journal of Electrical & Computer Engineering (BAJECE)
Reference19 articles.
1. A. Guo, M. Grabner, P. S. R., J. Elder, M. Sidovar, P. Aupperle, and S. Krieger, "Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis," ClinicoEconomics and Out¬comes Research: CEOR, vol. 8, pp. 177-186, 2016.
2. C. Asche, M. Singer, and M. e. a. Jhaveri, "All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the united states," J Manag Care Pharm., vol. 16, no. 9, p. 703-712,
2010.
3. K. Grice, K. Vogel, V. Le, A. Mitchell, S. Muniz, and M. Vollmer, "Adults norms for a commercially available nine-hole peg test for finger dexterity," American Journal of Occupational Therapy, vol. 57, no. 3, p. 570-573, 2003.
4. J. Kurtzke, "Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (edss)," Neurology, vol. 33, no. 1, p.
1444-1452, 1983.
5. R. Jebsen, N. Taylor, R. Trieschmann, M. Trotter, and L. Howard, "An objective and standardized test of hand function," Arch Phys Med
Rehabil., vol. 50, no. 6, p. 311-319, 1969.